PUBLISHER: The Business Research Company | PRODUCT CODE: 1717033
PUBLISHER: The Business Research Company | PRODUCT CODE: 1717033
Hemodynamic flow alteration devices are medical instruments designed to modify the dynamics of blood flow within the circulatory system. These devices are often utilized in procedures such as vascular surgery or heart condition treatments. They can influence factors such as the speed, direction, or resistance of blood flow to enhance circulation or reduce strain on vital organs.
The primary types of hemodynamic flow alteration devices include embolic protection devices and chronic total occlusion devices. An embolic protection device is specifically designed to capture and remove embolic material that may become dislodged during procedures such as angioplasty. This prevents the material from traveling to vital organs and causing blockages. These devices are used in various applications, including cardiovascular diseases, neurological disorders, renal conditions, and respiratory disorders, and are employed by several end users, including hospitals, clinics, ambulatory care centers, home care settings, and more.
The hemodynamic flow alteration devices market research report is one of a series of new reports from The Business Research Company that provides hemodynamic flow alteration devices market statistics, including the hemodynamic flow alteration devices industry global market size, regional shares, competitors with the hemodynamic flow alteration devices market share, detailed hemodynamic flow alteration devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodynamic flow alteration devices industry. This hemodynamic flow alteration devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The hemodynamic flow alteration devices market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth during the historic period can be attributed to factors such as the expanding aging population, increased healthcare expenditure, a rise in the prevalence of cardiovascular diseases, growing risk factors such as obesity, diabetes, and hypertension, and increased investment in research and development.
The hemodynamic flow alteration devices market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of neurovascular diseases, a growing demand for minimally invasive neurosurgery, a rise in geriatric patients, an increased risk of thrombotic events, and rising disposable incomes. Key trends in the forecast period include the adoption of minimally invasive procedures, advancements in biocompatible materials, the development of wearable monitoring systems, the integration of artificial intelligence and machine learning, and the incorporation of these devices with cardiac monitoring systems.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the hemodynamic flow alteration devices market. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The rise in CVD cases is primarily attributed to factors such as aging populations, unhealthy diets, sedentary lifestyles, and increasing rates of conditions such as hypertension and diabetes. Hemodynamic flow alteration devices are crucial for managing blood flow in patients with cardiovascular conditions such as heart failure, hypertension, and arterial blockages. For example, a report by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, with 4 million men and 3.6 million women affected. By 2030, this number is projected to increase by 1 million, and by 2040, it could rise by an additional 2 million. Thus, the growing prevalence of cardiovascular diseases is a key driver for the hemodynamic flow alteration devices market.
Leading companies in the hemodynamic flow alteration devices market are focusing on the development of advanced solutions such as left ventricular assist devices (LVADs) to provide better cardiac support, improve patient outcomes, and tackle the rising incidence of heart failure worldwide. An LVAD is a mechanical pump implanted in patients with severe heart failure to assist the heart in pumping blood. For example, in January 2022, the Indian Institute of Technology-Kanpur, a government research institute based in India, launched an initiative called Hridyantra. This project aims to develop a cutting-edge LVAD to meet the needs of patients with end-stage heart failure. The device is intended to either serve as a bridge to a heart transplant or provide a long-term solution for those who are not candidates for a transplant.
In October 2024, Johnson & Johnson, a pharmaceutical company based in the US, acquired V-Wave Inc. for an undisclosed sum. This acquisition is intended to bolster Johnson & Johnson's position in the cardiovascular disease sector by adding V-Wave's groundbreaking Ventura interatrial shunt to its MedTech portfolio. V-Wave Inc., a US-based company, specializes in the development of hemodynamic flow alteration devices.
Major players in the hemodynamic flow alteration devices market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Getinge AB, Lepu Medical Technology (Beijing) Co. Ltd., Abiomed Inc., LivaNova PLC, Cordis US Corp., Silk Road Medical Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., and CARMAT SA.
North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in hemodynamic flow alteration devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hemodynamic flow alteration devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hemodynamic flow alteration devices market consists of sales of flow diverters, vascular stents, blood flow regulators, and monitoring tools. Values in and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemodynamic Flow Alteration Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hemodynamic flow alteration devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hemodynamic flow alteration devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemodynamic flow alteration devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.